TSMC Boosts Revenue Forecast Amid AI Demand Surge, Declines US Joint Venture Offer

download 2024 08 09T115240.883

TSMC, the world’s largest contract chipmaker, has raised its full-year revenue forecast, citing a surge in demand for chips used in artificial intelligence. Despite this optimistic outlook, TSMC has dismissed the idea of a joint venture factory in the United States.

The company, a key supplier for tech giants like Apple and Nvidia, has benefited from the global AI boom, offsetting a decline in pandemic-driven electronics demand. On July 18, TSMC reported a net profit that exceeded market expectations and raised its 2024 revenue forecast to a growth rate of slightly above the mid-20% range in U.S. dollar terms, up from an earlier prediction of low to mid-20% growth.

Chairman and CEO C.C. Wei highlighted the intense interest in AI, stating, “AI is so hot; right now everybody, all my customers, want to put AI functionality into their devices.” Following the announcement, TSMC’s U.S.-listed shares rose 3.3% in pre-market trading, although its Taiwan-listed shares closed down 2.4% due to recent political tensions.

In response to recent comments by U.S. Republican presidential candidate Donald Trump about Taiwan’s chip business, TSMC reaffirmed its commitment to existing expansion plans without considering a U.S. joint venture. Wei emphasized that TSMC’s strategy remains unchanged, with ongoing expansions in Arizona, Japan, and potentially Europe.

TSMC is investing $65 billion in three plants in Arizona and has new factories in Japan and Germany. Despite the tight supply of advanced chips, including 3nm and 5nm nodes, the company is working to increase capacity to meet growing demand. For the current quarter, TSMC projects revenue between $22.4 billion and $23.2 billion, up to 34% higher than previous figures.

The company has adjusted its capital expenditure plans for the year to $30 billion to $32 billion, up from a previous forecast of $28 billion to $32 billion. TSMC’s second-quarter revenue climbed 33% year-on-year to $20.8 billion, surpassing earlier forecasts.

IMG 20240813 WA0004 e1723613011292

I’m a finance writer with  three years of experience in investment analysis. At Investorwelcome , I translate complex financial concepts into clear, actionable insights to help investors navigate the market with confidence. Combining my solid academic background with practical industry knowledge, I’m dedicated to providing readers with accurate and timely information. My goal is to empower both new and seasoned investors by simplifying intricate data and offering strategic advice. When I’m not writing, I stay engaged with market trends and investment innovations to ensure my content remains relevant and valuable.

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post
img 237226 wazirxexchange

WazirX to reverse all trades between July 18-21 after $230 million security breach

Next Post
GettyImages 1874681159 068e8f8d167e4d3c9bc851c136e30bdb

Eli Lilly’s Q2 Surge: Weight-Loss Drugs, Supply Milestones, and FDA Approvals Boost Stock

Related Posts